Hyundai Bioland

What Hyundai Bioland does

Hyundai Bioland Co., Ltd. is a South Korea-based privately held company headquartered in Cheongju-si, Chungcheongbuk-do, that manufactures and sells resorbable collagen membrane medical devices for the dental sector. The company's core product, T-Gen, is a resorbable collagen membrane composed of Type I collagen, manufactured using proprietary technology developed through over 15 years of collagen and hyaluronic acid research expertise. T-Gen is offered in three sizes (TG-1: 15mm × 20mm, TG-2: 20mm × 30mm, TG-3: 30mm × 40mm) and is used in guided bone regeneration (GBR) and periodontal tissue healing procedures, where it adheres to defect sites after hydration and can be fixed with sutures, bone tacks, or other methods.

The company sells its devices directly to dental professionals — periodontists, dental surgeons, and general dentists — and claims commercial distribution across more than 50 countries with safety certifications in 33 jurisdictions. Its go-to-market motion is event-driven, anchored on the major international dental congresses (EAO, IDS Cologne, AAP, AAOMS, EuroPerio, IDEX Istanbul), with no public pricing, no enterprise contracts, and no distributor identities disclosed. The biomedical department website launched in February 2024, and the company has expanded its commercial footprint annually across Europe, North America, and the Middle East.

Beyond dental regenerative devices, Hyundai Bioland is extending into the nutraceutical category through a strategic partnership with Pharmactive Biotech Products. In February 2026 the collaboration secured MFDS individual license approval for Affron saffron extract as a stress-relief Health Functional Food ingredient in South Korea — the first and sole saffron ingredient to hold this recognition in the country. This nutraceutical line targets a distinct customer set (supplement manufacturers and pharmacy channels) from the dental practitioner base, signaling a planned diversification of revenue streams beyond a single biomaterial SKU.

Name

Hyundai Bioland

Legal name

HYUNDAI BIOLAND

Website

https://hyundaibiolandmedical.com

Company type

Private

Founded year

2024

Operating status

Operating

Short description

South Korean medical device company manufacturing T-Gen resorbable collagen membranes for dental guided bone regeneration and periodontal tissue healing, serving periodontists and dental surgeons in over 50 countries, with a recent extension into MFDS-approved nutraceuticals.

Ownership category

akta.pro rank

Product category

Dental Biomaterials

NAICS

Dental Equipment and Supplies Manufacturing (339114)

SIC

Dental Equipment & Supplies (3843)

akta.pro primary industry

Periodontal Regeneration (GTR/EMD/Biologics) (HLABACAI)

akta.pro secondary industry

Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics) (HLAHAEAE)

Keywords

• Dental biomaterials
• Collagen membrane
• Guided bone regeneration
• Resorbable membrane
• Periodontal tissue regeneration

Headquarters

HQ city

Chongwon

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel

Revenue model

1. Medical Device Sales: Sale of resorbable collagen membrane products for dental procedures, targeting periodontal tissue regeneration and guided bone regeneration applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Hyundai Bioland manufactures and sells resorbable collagen membranes under the T-Gen brand, composed of Type I collagen, used in dental procedures such as guided bone regeneration (GBR) to promote healing of damaged alveolar bone and periodontal tissue. The product is available in three sizes (TG-1: 15mm x 20mm, TG-2: 20mm x 30mm, TG-3: 30mm x 40mm) and is targeted at periodontists, dental surgeons, and general dentists globally.

Product overview

Hyundai Bioland specializes in researching and providing biomaterials with expertise in collagen and hyaluronic acid manufacturing techniques. The company's primary product is the Resorbable Collagen Membrane (T-Gen), a biomedical material for dental procedures used in guided bone regeneration (GBR) techniques. The product is available in three sizes (TG-1: 15mm X 20mm, TG-2: 20mm X 30mm, TG-3: 30mm X 40mm) to accommodate different defect sizes. Products are certified for safety in 33 countries and distributed in over 35 countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• T-Gen: Resorbable collagen membrane product for dental procedures, manufactured based on proprietary technology encompassing over 15 years of collagen research expertise, composed of type I collagen. Used for guided bone regeneration (GBR) and healing of damaged alveolar bone or periodontal tissue. Available in 3 sizes (TG-1: 15mm X 20mm, TG-2: 20mm X 30mm, TG-3: 30mm X 40mm).

Products and services

• T-Gen Resorbable Collagen Membrane A resorbable collagen membrane composed of Type I collagen manufactured using proprietary technology developed through over 15 years of collagen research expertise. It is designed for dental procedures such as guided bone regeneration (GBR), promoting healing of damaged alveolar bone and periodontal tissue. The membrane adheres well to defect sites after hydration and can be fixed using sutures, bone tack, and other methods. Available in three sizes: TG-1 (15mm x 20mm), TG-2 (20mm x 30mm), and TG-3 (30mm x 40mm). Targeted at periodontists, dental surgeons, and general dentists.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Pharmactive Biotech ProductscoreStrategic or Co-development Partner · 10 February 2026Hyundai Bioland collaborated with Pharmactive Biotech Products in the approval process for Affron® saffron extract, which received individual license approval from South Korea's Ministry of Food and Drug Safety (MFDS) for a stress relief health claim. This collaboration, taking over two years, made Affron® the first and sole saffron ingredient to hold this recognition in South Korea. Hyundai Bioland's involvement enabled supplements containing Affron® to bear the Health Functional Food (HFF) seal in South Korea.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hyundai Bioland